PTSD Marijuana References

Equal Medicine Organization Medical Marijuana Rx Card Cannabis Cultivation

PTSD Marijuana References

 

  1. Betthauser, K., Pilz, J., and Vollmer, L.E. (2015, August). Use and effects of cannabinoids in military veterans with posttraumatic stress disorder. American Journal of Health-System Pharmacy, 72(15), 1279-84. Retrieved from http://www.ajhp.org/content/72/15/1279.long.
  2. Boden, M.T., Babson, K.A., Vujanovic, A.A., Short, N.A., and Bonn-Miller, M.O. (2013, May-June). Post-traumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence. The American Journal on Addictions, 22(3), 277-84. Retrieved from http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1521-0391.2012.12018.x/full.
  3. Bonn-Miller, M.O., Babson, K.A., and Vandrey, R. (2014, March 1). Using cannabis to help you sleep: heightened frequency of medical cannabis use among those with PTSD. Drug and Alcohol Dependence, 136, 162-5. Retrieved from http://www.sciencedirect.com/science/article/pii/S0376871613005243.
  4. Bonn-Miller, M.O., Vujanovic, A.A., and Drescher, K.D. (2011, September). Cannabis use among military veterans after residential treatment for posttraumatic stress disorder. Psychology of Addictive Behavior, 25(3), 485-91. Retrieved from https://msrc.fsu.edu/system/files/Bonn-Miller%20et%20al%202011Cannabis%20use%20among%20military%20veterans%20after%20residential%20treatment%20for%20posttraumatic%20stress%20disorder.pdf.
  5. Greer, G.R., Grob, C.S., and Halberstadt, A.L. (2014, January-March). PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program. Journal of Psychoactive Drugs, 46(1), 73-7. Retrieved from http://www.tandfonline.com/doi/full/10.1080/02791072.2013.873843?needAccess=true.
  6. Korem, N., and  Akirav, I. (2014). Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing. Neuropsychopharmacology, 39(12), 2709–2722. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200492/.
  7. Lu, A.T., Ogdie, M.N., Järvelin, M.R., Moilanen, I.K., Loo, S.K., McCracken, J.T., McGough, J.J., Yang, M.H., Peltonen, L., Nelson, S.F., Cantor, R.M., and Smalley, S.L. (2008). Association of the Cannabinoid Receptor Gene (CNR1) With ADHD and Post-Traumatic Stress Disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : The Official Publication of the International Society of Psychiatric Genetics, 147B(8), 1488–1494. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685476/.
  8. Neumeister, A., Normandin, M.D., Pietrzak, R.H., Piomelli, D., Zheng, M.Q., Gujarro-Anton, A., Potenza, M.N., Bailey, C.R., Lin, S.F., Najafzadeh, S., Ropchan, J., Henry, S., Corsi-Travali, S., Carson, R.E., and Huang, Y. (2013). Elevated Brain Cannabinoid CB1 Receptor Availability in Posttraumatic Stress Disorder: A Positron Emission Tomography Study. Molecular Psychiatry, 18(9), 1034–1040. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752332/.
  9. Passie, T., Emrich, H.M., Karst, M., Brandt, S.D., and Halpern, J.H. (2012, July-August). Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence. Drug Testing and Analysis, 4(7-8), 649-59. Retrieved from http://onlinelibrary.wiley.com/wol1/doi/10.1002/dta.1377/full.
  10. Post-traumatic stress disorder (PTSD). (2014, April 15). Mayo Clinic. Retrieved from http://www.mayoclinic.org/diseases-conditions/post-traumatic-stress-disorder/basics/definition/con-20022540.
  11. Potter, C.M., Vujanovic, A.A., Marshall-Verenz, E.C., Bernstein, A., and Bonn-Miller, M.O. (2011, April). Posttraumatic stress and marijuana use coping motives: the mediating role of distress tolerance. Journal of Anxiety Disorders, 25(3), 437-43. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101637/.
  12. Roitman, P., Mechoulam, R., Cooper-Kazaz, R., and Shalev, A. (2014, August). Preliminary, open-­label, pilot study of add-­on oral Δ9-­tetrahydrocannabinol in chronic post-­traumatic stress disorder. Clinical Drug Investigation, 34(8), 587-591. Retrieved from http://link.springer.com/article/10.1007%2Fs40261-014-0212-3.
  13. Walsh, Z., Gonzalez, R., Crosby, K., S Thiessmen, M., Carroll, C., and Bonn-Miller, M.O. (2016, October 12). Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review, 51, 15-29. Retrieved from http://www.sciencedirect.com/science/article/pii/S0272735816300939.
  14. What is Post-traumatic Stress Disorder (PTSD)? (n.d.). National Institute of Mental Health. Retrieved from http://www.nimh.nih.gov/health/topics/post-traumatic-stress-disorder-ptsd/index.shtml.
  15. Wilker, S., Pfeiffer, A., Elbert, T., Ovuga, E., Karabatsiakis, A., Krumbholz, A., Thieme, D., Schelling, G., and Kolassa, I.T. (2016, May). Endocannabinoid concentrations in hair are associated with PTSD symptom severity. Psychoneuroendocrinology, 67, 198-206. Retrieved from http://www.psyneuen-journal.com/article/S0306-4530(16)30040-3/fulltext.

Equal Medicine Organization Medical Marijuana Cannabis Cultivation